Regulatory PathRegulatory requirements compared

Active substances

Captopril + Hydrochlorothiazide

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
CAPOZIDE TABLET50, 25 mgTablet · Oral use28 BlisterSAR 73.00NCE · PrescriptionBRISTOL-MYERS SQUIBBWithdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
CAPTOPRIL AND HYDROCHLOROTHIAZIDE25MG;15MG; 25MG;25MG; 50MG;25MG; 50MG;15MGtablet · oralRISINGPrescription29 Dec 1997
CAPOZIDE 25/1525MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**tablet · oralAPOTHECONDiscontinued12 Oct 1984
CAPOZIDE 25/2525MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**tablet · oralAPOTHECONDiscontinued12 Oct 1984
CAPOZIDE 50/2550MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**tablet · oralAPOTHECONDiscontinued12 Oct 1984
CAPOZIDE 50/1550MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**tablet · oralAPOTHECONDiscontinued12 Oct 1984
CAPTOPRIL AND HYDROCHLOROTHIAZIDE25MG;15MG; 25MG;25MG; 50MG;25MG; 50MG;15MGtablet · oralSTRIDES PHARMA INTLDiscontinued29 Dec 1997
CAPTOPRIL AND HYDROCHLOROTHIAZIDE25MG;15MG; 25MG;25MG; 50MG;25MG; 50MG;15MGtablet · oralCOSETTE PHARMS NCDiscontinued29 Dec 1997
CAPTOPRIL AND HYDROCHLOROTHIAZIDE50MG;25MGtablet · oralWATSON LABSDiscontinued29 Dec 1997
CAPTOPRIL AND HYDROCHLOROTHIAZIDE25MG;15MG; 25MG;25MG; 50MG;25MG; 50MG;15MGtablet · oralIVAX SUB TEVA PHARMSDiscontinued18 Jun 1998

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.